Thursday, March 20th , 2025- Day 3 Main Conference - EST/EDT (Eastern Daylight, GMT-4)
- Kevin Hagan - CEO, PAN Foundation
- Joshua Walsh - Director of Patient Access, Abbvie
- Hear real “Cinderella stories” of patients who moved from receiving charity care to thriving independently
- Discover how to cultivate empowering empathy while avoiding burnout in the nonprofit healthcare space
- Joshua Pearson, PharmD, RPh - Director of Pharmacy Services and Clinical Pharmacist, Health Partners Free Clinic
Join Genentech and Milliman for an insightful session exploring the intricacies of pharmacy alternative funding programs (AFPs) and patient assistance programs. We'll cover the following key topics:
- Understanding the impact of Alternative Funding Programs and examine the potential effects on patients and healthcare providers
- Gain insight into considerations for Self-Funded Plan Sponsors and explore important factors self-funded plan sponsors should evaluate when considering AFPs
- Learn how to assist patients in overcoming access challenges associated with AFPs
- Understand Genentech’s Commitment to educating employers, benefit consultants and patients on AFPs and Milliman’s Insights on AFPs including:
- Assess the financial impact of AFPs on specialty drug costs for self-funded plans
- Understand the associated fees related to employing AFPs
- Review regulatory and compliance aspects for self-funded plan sponsors when implementing AFPs
- Corey Belken, PharmD - Principle - National Employer Team, Genentech
- Julia Shelton, PharmD - Senior Pharmacy Management Consultant, Milliman
- Thuan Tran - Health Equity Lead, Genentech Patient Foundation
- Explore the real-world impact of patient assistance programs from the patient perspective, highlighting challenges, successes and areas for improvement
- Discuss strategies for navigating support programs to ensure patients receive the care and resources they need
- Examine the role of patient advocacy groups in shaping access to treatment, providing support and driving meaningful change in healthcare
- Jessica Smith - Founder and CEO, Living Well With Epilepsy; Executive Director, American Society for Experimental Neurotherapeutics
- James Romano - Founder, Care & Cure Partners
Explore the complexities of patient expenses and how charitable contributions have influenced financial access to care
Uncover what OOP costs really look like and discuss the effectiveness of donations in alleviating financial burdens
Gain insights into the intersection of charity, patient support and the ongoing challenges in ensuring affordable access to treatment
- Jonathan James - Chief Executive Officer, Hope Charities
- Alan Klein - Chief Growth and Strategy Officer, PAN Foundation
- Kelly Green - Executive Director, Help Hope Live
Digital health is transforming the way patients and providers interact, offering new opportunities to improve engagement, streamline care, and enhance satisfaction. This session will explore the evolving role of digital health from both patient and provider perspectives. We will discuss real-world applications of digital tools used in clinics, as well as the technologies patients are adopting to manage their health. Topics will include remote patient monitoring, AI-driven decision support, patient portals, and telehealth solutions. By examining these innovations, we will highlight how digital health fosters better communication, supports shared decision-making, and ultimately leads to improved health outcomes. Join us for an interactive discussion on the future of digital health and how to optimize its impact in clinical practice.
- Jin Lee - Investor, Oxford Angel Fund
- Shamekka Marty - Ambassador, National Minority Health Association
With the election behind us and a new administration in place, the impact on healthcare legislation and regulatory priorities is coming into focus. This session examines key policy shifts, congressional dynamics and the evolving relationship between government and the healthcare life sciences sector.
- Assess how the new administration’s priorities and congressional leadership changes are shaping healthcare policies, including drug pricing, market access, and patient assistance programs
- Examine the possible implications for industry
- Gain strategic insights into navigating the evolving political landscape, preparing for potential legislative changes and engaging effectively with policymakers
- Max Bronstein - President, MGB Consulting
- Rachel Nuzum - Senior Vice President, Policy, The Commonwealth Fund
- Shanelle Gabriel - Lupus Patient Advocate & Artist, Building Constellations LLC